{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:08:17Z","timestamp":1767625697930,"version":"3.40.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"South African National Research Foundation","award":["NRF Grant 103805"],"award-info":[{"award-number":["NRF Grant 103805"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10719-021-09991-x","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T08:02:53Z","timestamp":1615795373000},"page":"411-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular modeling provides insights into the loading of sialic acid\u2010containing antigens onto CRM197: the role of chain flexibility in conjugation efficiency and glycoconjugate architecture"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-4632","authenticated-orcid":false,"given":"Michelle M.","family":"Kuttel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8476-5630","authenticated-orcid":false,"given":"Neil","family":"Ravenscroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"issue":"8","key":"9991_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S1473-3099(17)30301-8","volume":"17","author":"CL Trotter","year":"2017","unstructured":"Trotter, C.L., et al.: Impact of MenAfriVac in nine countries of the African meningitis belt, 2010\u201315: an analysis of surveillance data. Lancet. Infect. Dis 17(8), 867\u2013872 (2017)","journal-title":"Lancet. Infect. Dis"},{"key":"9991_CR2","doi-asserted-by":"publisher","unstructured":"Pizza, M., Bekkat-Berkani, R., Rappuoli, R.: Vaccines against meningococcal diseases. Microorganisms 8(10), 1521 (2020).\u00a0https:\/\/doi.org\/10.3390\/microorganisms8101521","DOI":"10.3390\/microorganisms8101521"},{"key":"9991_CR3","doi-asserted-by":"crossref","unstructured":"McDonald, N.D., Boyd, E.F.:\u00a0Structural and biosynthetic diversity of nonulosonic acids (NulOs) that decorate surface structures in bacteria. Trends Microbiol. 29(2), 142\u2013157 (2021)","DOI":"10.1016\/j.tim.2020.08.002"},{"key":"9991_CR4","doi-asserted-by":"crossref","unstructured":"Berti, F.: Multivalent meningococcal conjugate vaccines: chemical conjugation strategies used for the preparation of vaccines licensed or in clinical trials. In:\u00a0Prasad K. (ed.)\u00a0Carbohydrate-based vaccines: from concept to clinic, p.\u00a0123\u2013137. American Chemical Society, Washington, D.C. (2018)","DOI":"10.1021\/bk-2018-1290.ch006"},{"issue":"18","key":"9991_CR5","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.vaccine.2008.01.022","volume":"26","author":"A Bardotti","year":"2008","unstructured":"Bardotti, A., et al.: Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases. Vaccine 26(18), 2284\u20132296 (2008)","journal-title":"Vaccine"},{"issue":"22","key":"9991_CR6","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1016\/S0264-410X(99)00092-4","volume":"17","author":"N Ravenscroft","year":"1999","unstructured":"Ravenscroft, N., et al.: Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines. Vaccine 17(22), 2802\u20132816 (1999)","journal-title":"Vaccine"},{"issue":"16","key":"9991_CR7","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.vaccine.2004.10.021","volume":"23","author":"A Bardotti","year":"2005","unstructured":"Bardotti, A., Berti, A.G., Berti, F., Galli, S., Giannini, C., Fabbri, S., Proietti, B., Ravenscroft, D., Ricci, N. S.: Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135. Vaccine 23(16), 1887\u20131899 (2005)","journal-title":"Vaccine"},{"issue":"20","key":"9991_CR8","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1002\/1521-3765(20011015)7:20<4411::AID-CHEM4411>3.0.CO;2-T","volume":"7","author":"DJ Lefeber","year":"2001","unstructured":"Lefeber, D.J., Kamerling, J.P., Vliegenthart, J.F.: Synthesis of Streptococcus pneumoniae type 3 neoglycoproteins varying in oligosaccharide chain length, loading and carrier protein. Chem. Eur. J. 7(20), 4411\u20134421 (2001)","journal-title":"Chem. Eur. J."},{"issue":"6","key":"9991_CR9","first-page":"943","volume":"221","author":"F Carboni","year":"2020","unstructured":"Carboni, F., et al.: Evaluation of immune responses to group B streptococcus type III oligosaccharides containing a minimal protective epitope. J. Infect. Dis. 221(6), 943\u2013947 (2020)","journal-title":"J. Infect. Dis."},{"key":"9991_CR10","doi-asserted-by":"crossref","unstructured":"Schumann, B., et al.: A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine. Sci. Transl. Med. 9(380),\u00a0eaaf5347 (2017)","DOI":"10.1126\/scitranslmed.aaf5347"},{"issue":"4\u20136","key":"9991_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/07328303.2011.604453","volume":"30","author":"R Adamo","year":"2011","unstructured":"Adamo, R., et al.: Synthesis of laminarin fragments and evaluation of a \u03b2-(1, 3) glucan hexasaccaride-CRM197 conjugate as vaccine candidate against Candida albicans. J. Carbohydr. Chem. 30(4\u20136), 249\u2013280 (2011)","journal-title":"J. Carbohydr. Chem."},{"key":"9991_CR12","doi-asserted-by":"crossref","unstructured":"Micoli, F., et al.: Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proc. Natl. Acad. Sci. U.S.A. 110(47), 19077\u201319082 (2013)","DOI":"10.1073\/pnas.1314476110"},{"issue":"45","key":"9991_CR13","doi-asserted-by":"publisher","first-page":"13198","DOI":"10.1002\/anie.201506112","volume":"54","author":"G Stefanetti","year":"2015","unstructured":"Stefanetti, G., et al.: Sugar\u2013protein connectivity impacts on the immunogenicity of site-selective Salmonella O\u2010Antigen glycoconjugate vaccines. Angew. Chem. Int. Ed. Engl. 54(45), 13198\u201313203 (2015)","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"7","key":"9991_CR14","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.vaccine.2018.12.073","volume":"37","author":"L Xu","year":"2019","unstructured":"Xu, L., et al.: Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein. Vaccine 37(7), 956\u2013964 (2019)","journal-title":"Vaccine"},{"key":"9991_CR15","doi-asserted-by":"crossref","unstructured":"Kuttel, M.M., Ravenscroft, N.: The role of molecular modeling in predicting carbohydrate antigen conformation and understanding vaccine immunogenicity. In: Carbohydrate-based vaccines: from concept to clinic,\u00a0p. 139\u2013173. ACS Publications,\u00a0Washington, D.C, (2018)","DOI":"10.1021\/bk-2018-1290.ch007"},{"key":"9991_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.carres.2017.05.004","volume":"446","author":"MM Kuttel","year":"2017","unstructured":"Kuttel, M.M., Timol, Z., Ravenscroft, N.: Cross-protection in Neisseria meningitidis serogroups Y and W polysaccharides: A comparative conformational analysis. Carbohydr. Res. 446, 40\u201347 (2017)","journal-title":"Carbohydr. Res."},{"key":"9991_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.carres.2018.06.007","volume":"465","author":"J Hlozek","year":"2018","unstructured":"Hlozek, J., Kuttel, M.M., Ravenscroft, N.: Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation. Carbohyd. Res. 465, 44\u201351 (2018)","journal-title":"Carbohyd. Res."},{"issue":"16","key":"9991_CR18","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jcc.20289","volume":"26","author":"JC Phillips","year":"2005","unstructured":"Phillips, J.C., et al.: Scalable molecular dynamics with NAMD. J. Comput. Chem. 26(16), 1781\u20131802 (2005)","journal-title":"J. Comput. Chem."},{"issue":"16","key":"9991_CR19","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/jcc.20829","volume":"28","author":"JE Stone","year":"2007","unstructured":"Stone, J.E., et al.: Accelerating molecular modeling applications with graphics processors. J. Comput. Chem. 28(16), 2618\u20132640 (2007)","journal-title":"J. Comput. Chem."},{"issue":"22","key":"9991_CR20","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1002\/jcc.24428","volume":"37","author":"MM Kuttel","year":"2016","unstructured":"Kuttel, M.M., St\u00e5hle, J., Widmalm, G.: CarbBuilder: Software for building molecular models of complex oligo-and polysaccharide structures. J. Comput. Chem. 37(22), 2098\u20132105 (2016)","journal-title":"J. Comput. Chem."},{"key":"9991_CR21","doi-asserted-by":"crossref","unstructured":"Kuttel, M., et al.: (2011)\u00a0CarbBuilder: an adjustable tool for building 3D molecular structures of carbohydrates for molecular simulation. In:\u00a02011 IEEE Seventh International Conference on eScience. IEEE, New York (2011)","DOI":"10.1109\/eScience.2011.61"},{"issue":"9","key":"9991_CR22","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1021\/ct900242e","volume":"5","author":"O Guvench","year":"2009","unstructured":"Guvench, O., et al.: CHARMM additive all-atom force field for glycosidic linkages between hexopyranoses. J. Chem. Theory Comput. 5(9), 2353\u20132370 (2009)","journal-title":"J. Chem. Theory Comput."},{"issue":"15","key":"9991_CR23","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1002\/jcc.21004","volume":"29","author":"O Guvench","year":"2008","unstructured":"Guvench, O., et al.: Additive empirical force field for hexopyranose monosaccharides. J. Comput. Chem. 29(15), 2543\u20132564 (2008)","journal-title":"J. Comput. Chem."},{"issue":"2","key":"9991_CR24","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W.L., et al.: Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79(2), 926\u2013935 (1983)","journal-title":"J. Chem. Phys."},{"issue":"1","key":"9991_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A., Schulten, K.: VMD: visual molecular dynamics. J. Mol. Graph. 14(1), 33\u201338 (1996)","journal-title":"J. Mol. Graph."},{"issue":"5","key":"9991_CR26","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna, G.J., Tobias, D.J., Klein, M.L.: Constant pressure molecular dynamics algorithms. J. Chem. Phys. 101(5), 4177\u20134189 (1994)","journal-title":"J. Chem. Phys."},{"issue":"11","key":"9991_CR27","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1063\/1.470648","volume":"103","author":"SE Feller","year":"1995","unstructured":"Feller, S.E., et al.: Constant pressure molecular dynamics simulation: the Langevin piston method. J. Chem. Phys. 103(11), 4613\u20134621 (1995)","journal-title":"J. Chem. Phys."},{"issue":"12","key":"9991_CR28","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D., Pedersen, L.: Particle mesh Ewald: An N\u22c5log (N) method for Ewald sums in large systems. J. Chem. Phys. 98(12), 10089\u201310092 (1993)","journal-title":"J. Chem. Phys."},{"key":"9991_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/cbic.201300785","volume":"15","author":"S Crotti","year":"2014","unstructured":"Crotti, S., et al.: Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mapping. ChemBioChem 15, 836\u2013843 (2014)","journal-title":"ChemBioChem"},{"key":"9991_CR30","doi-asserted-by":"crossref","unstructured":"M\u00f6ginger, U., Resemann, A., Martin, C.E., Parameswarappa, S., Govindan, S., Wamhoff, E.C., et al.: Cross reactive material 197\u00a0glycoconjugate vaccines contain privileged conjugation sites. Sci. Rep. 6(1), 1\u201313 (2016)","DOI":"10.1038\/srep20488"},{"key":"9991_CR31","unstructured":"Ravenscroft, N.: The application of NMR spectroscopy to track the industrial preparation of polysaccharide and derived glycoconjugate vaccines, pp. 131\u2013144. Pharmeuropa, Special Edition (2000)"},{"key":"9991_CR32","doi-asserted-by":"crossref","unstructured":"Fusco, P.C., Farley, E.K., Huang, C.H., Moore, S., Michon, F.: Protective meningococcal capsular polysaccharide epitopes and the role of O\u00a0acetylation. Clin. Vaccine Immunol. 14(5), 577\u2013584 (2007)","DOI":"10.1128\/CVI.00009-07"},{"key":"9991_CR33","first-page":"151","volume":"103","author":"F Michon","year":"2000","unstructured":"Michon, F., et al.: Structure activity studies on group C meningococcal polysaccharideprotein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope. Dev. Biol. Basel 103, 151\u2013160 (2000)","journal-title":"Dev. Biol. Basel"},{"key":"9991_CR34","doi-asserted-by":"publisher","first-page":"35588","DOI":"10.1038\/srep35588","volume":"6","author":"AS Abdelhameed","year":"2016","unstructured":"Abdelhameed, A.S., et al.: Solution conformation and flexibility of capsular polysaccharides from Neisseria meningitidis and glycoconjugates with the tetanus toxoid protein. Sci. Rep. 6, 35588 (2016)","journal-title":"Sci. Rep."},{"key":"9991_CR35","doi-asserted-by":"crossref","unstructured":"Prasad, A.K., Kim, J., Gu, J.: Design and development of glycoconjugate vaccines. In:\u00a0Prasad, K. (ed.)\u00a0Carbohydrate-based vaccines: from concept to clinic, p.\u00a075\u2013100. American Chemical Society,\u00a0Washington, D.C\u00a0(2018)","DOI":"10.1021\/bk-2018-1290.ch004"}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-021-09991-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10719-021-09991-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-021-09991-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T05:56:32Z","timestamp":1744091792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10719-021-09991-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9991"],"URL":"https:\/\/doi.org\/10.1007\/s10719-021-09991-x","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"type":"print","value":"0282-0080"},{"type":"electronic","value":"1573-4986"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"F.B. is an employee of the GSK companies.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.\u00a0","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}